PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.\', \'NewYork-Presbyterian Hospital/Weill Cornell Medical Campus, New York, NY, USA.\', \'ET HealthCare, Palo Alto, CA, USA.\', \'Laboratory of Molecular Immunology, Rockefeller University, New York, NY, USA.\', \'Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA.\', \'School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.\', \'Howard Hughes Medical Institute, Chevy Chase, MD, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/clinchem/hvab069
?:doi
?:hasPublicationType
?:journal
  • Clinical chemistry
is ?:pmid of
?:pmid
?:pmid
  • 33914041
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.281
?:rankingScore_hIndex
  • 195
?:title
  • TOP-Plus Is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33914041>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33914041>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all